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Abstract
Introducion: With the increasing number of children exposed to HIV or antiretroviral therapy in utero, there are concerns that
this population may have worse neurodevelopmental outcomes compared to those who are unexposed. The objective of this
study was to systematically review the clinical and preclinical literature on the effects of in utero exposure to HIV and/or
antiretroviral therapy (ART) on neurodevelopment.
Methods: We systematically searched OVID Medline, PsycINFO and Embase, as well as the Cochrane Collaborative Database,
Google Scholar and bibliographies of pertinent articles. Titles, abstracts, and full texts were assessed independently by two
reviewers. Data from included studies were extracted. Results are summarized qualitatively.
Results: The search yielded 3027 unique titles. Of the 255 critically reviewed full-text articles, 25 met inclusion criteria for
the systematic review. Five articles studied human subjects and looked at brain structure and function. The remaining 20 arti-
cles were preclinical studies that mostly focused on behavioural assessments in animal models. The few clinical studies had
mixed results. Some clinical studies found no difference in white matter while others noted higher fractional anisotropy and
lower mean diffusivity in the brains of HIV-exposed uninfected children compared to HIV-unexposed uninfected children, cor-
relating with abnormal neurobehavioral scores. Preclinical studies focused primarily on neurobehavioral changes resulting from
monotherapy with either zidovudine or lamivudine. Various developmental and behavioural changes were noted in preclinical
studies with ART exposure, including decreased grooming, decreased attention, memory deficits and fewer behaviours associ-
ated with appropriate social interaction.
Conclusions: While the existing literature suggests that there may be some neurobehavioral differences associated with HIV
and ART exposure, limited data are available to substantially support these claims. More research is needed comparing neuro-
biological factors between HIV-exposed uninfected and HIV-unexposed uninfected children and using exposures consistent
with current clinical care.
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1 | INTRODUCTION
For the 1.4 million children born annually to mothers living
with HIV, there are concerns that HIV or antiretroviral ther-
apy (ART) exposure may negatively impact neurodevelopment,
including cognition, language and motor skills [1,2]. A meta-
analysis on neurodevelopment in HIV-exposed uninfected
(HEU) children highlighted the limitations in the current body
of literature including the heterogeneity of the patient popula-
tions between studies, limited confounders measured and
variability in ART regimens. More recent studies are often lim-
ited by sample size and have mixed results [3-5].
There are inherent challenges in studying the effects of HIV
and ART on neurodevelopment. Children’s brains undergo
rapid growth and restructuring from birth to adolescence, so
functional expressions of neurodevelopmental systems dam-
aged in utero may not be easily detectable early in life or may
not manifest until later [6]. For example, most assessments
performed on young children measure general categories of
neurodevelopment, such as overall cognitive ability. This
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prevents more refined analysis of processing speed, working
memory and fluid reasoning, which can be measured with
greater psychometric rigor when children are older. An addi-
tional challenge is delineating the direct effects of HIV expo-
sure compared to ART exposure. Prospectively evaluating HIV
exposure in utero without ensuring the pregnant mother is
also on ART is unethical. However, this delineation could be
critical if HEU children were found to have worse neurodevel-
opmental outcomes.
To overcome some of these challenges, there is a need for
both clinical studies using highly sensitive and quantifiable
tools and preclinical studies controlling biological states, to
delineate the effects of HIV from ART. The objective of this
study was to systematically review the clinical and preclinical
literature on the effects of in utero exposure to HIV and/or
ART on neurodevelopment.
2 | METHODS
2.1 | Search strategy
We conducted a systematic search using a protocol designed
by a medical librarian (EW) in accordance with PRISMA guide-
lines [7]. Ovid MEDLINE, PsycINFO and Embase were
searched on 17 October 2017 using a comprehensive search
strategy (Table S1). On 20 January 2018, we searched Google
Scholar, Cochrane Database for Systematic Reviews and the
bibliographies of pertinent articles.
The initial screening of titles and abstracts was performed
by two independent reviewers (MM and KB). Articles were
excluded if they did not include a population exposed to either
ART or HIV in utero or did not look at a neurological outcome.
Full texts of the remaining articles were independently
reviewed (MM and KB) to determine whether articles met the
complete predetermined eligibility criteria, with disagreements
between the reviewers settled after discussion.
2.2 | Eligibility
Inclusion criteria: 1) a population either exposed to ART in
utero or exposed to HIV in utero without contracting the virus,
and 2) primary outcome was an objective measure of neuro-
logical or cognitive status. For clinical studies, which inher-
ently involve human subjects, this included: measuring brain
structure, brain response, or neurobiomarkers with or without
a neurodevelopmental assessment. An emphasis was placed
on more quantitative measures of brain structure, response
and neurobiomakers, in order to minimize variation in the
interpretation of neurodevelopmental assessments alone,
which primarily assess behaviour that can be culturally depen-
dent and often use different scales for standardization. For
preclinical studies involving animal models, this included: mea-
suring brain structure, brain response, neurobiomarkers or
neurodevelopmental assessment. Additionally, for preclinical
rodent studies, exposure to ART or HIV-related proteins prior
to postnatal day 7 was considered prenatal exposure, consis-
tent with known benchmarks of neurological maturation
between human and rodent foetuses [8]. Exclusion criteria:
studies that only focused on HIV-infected populations or used
HEU populations only as a control; studies that only mea-
sured neurodevelopment in humans (due to the existence of
prior related reviews and known heterogeneity in quality of
assessments); review articles; published abstracts without full-
text publications; and case study reports containing < 5 par-
ticipants.
2.3 | Quality assessment
Quality of clinical and preclinical studies was assessed using
The Strength of Evidence Tool [9] and the Animal Research:
Reporting of In Vivo Experiments (ARRIVE) guidelines [10]
respectively. Reviewers independently rated each article, and
disagreements were settled after discussion by consensus
(Tables S2 and S3).
2.4 | Data extraction
Study data were extracted into an electronic table by one
reviewer (MM) and cross-checked independently by the sec-
ond reviewer (KB), including study design, study population/
model organism, exposures, neurological/cognitive/biological
outcomes measured, main results and limitations. Data were
described qualitatively.
3 | RESULTS
The searches yielded 3027 unique titles. Post-screening, 255
full-text articles were critically reviewed, and 25 met inclusion
criteria for the systematic review (Figure 1). Five articles
included human subjects and studied brain size, structure and
function [11-15]. The remaining 20 articles were preclinical
studies using animal models mostly focused on behavioural
assessments (see Tables 1 and 2 for study characteristics and
summary of outcomes).
3.1 | Clinical studies
Four studies looked at magnetic resonance imaging (MRI) find-
ings in HEU populations; two were performed in South Africa
[12,15], one in France [14] and one in Thailand [11]. In terms
of methodological quality, one study was rated as good [12],
two were fair-good [13,15] and two were fair [11,14]. Three
studies used diffusion tensor imaging (DTI) [11,12,15]. Two
noted regionally higher fractional anisotropy (FA) and predom-
inantly lower diffusivity in HEU compared to HUU, in both
neonates and children [12,15]. Higher FA was noted in the
middle cerebellar peduncles and right posterior corona radiata
[12,15], and lower diffusivity was noted in bilateral regions of
the corticospinal tract, while the posterior corona radiata
showed both significant increases and decreases in different
diffusivity metrics [12]. Abnormal Dubowitz neurobehavioral
scores were positively correlated with FA in the left uncinate
fasciculus and negatively correlated with diffusivity in the right
inferior cerebellar peduncle and bilateral hippocampal cingu-
lum in HEU infants [15]. The third study using DTI in age-
matched HEU and HUU children did not detect group differ-
ences in intelligence quotient (IQ) scores, brain volume, or DTI
metrics, after controlling for sociodemographic factors [11].
This study found that DTI measures were significantly associ-
ated with full scale and performance IQ scores, showing posi-
tive associations with FA and negative associations with
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diffusivity metrics. Subscale analyses showed the strongest
effects between perceptual organization scores and diffusivity
in the internal capsule, cingulum, and optic/temporal regions,
including the uncinate and thalamic radiations [11].
The fourth MRI study only looked at HEU children (n = 49)
and found that 50% showed MRI abnormalities, including dif-
fuse hyperintensity in the white matter and pontine tegmen-
tum [14]. Additionally, cerebral volume loss was seen in 10
children [14]. This study was a retrospective chart review of
HEU infants and toddlers, the majority (88%) of whom were
symptomatic, introducing sample bias towards abnormality
[14].
One study looked at brainstem auditory evoked potentials,
and showed significant delays of wave I and I-III interwave
intervals in HEU infants exposed in utero to zidovudine alone
or in combination with lamivudine [13]. The authors suggested
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Figure 1. PRISMA flowchart.
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that these findings may indicate toxicity in the lower regions
of the brainstem in HEU infants [13].
3.2 | Preclinical studies
Of the 20 preclinical articles, 15 evaluated exposure to ART
monotherapy (either zidovudine or lamivudine) [16,18–21,23–
25,27–29,31,32,34,35], two exposure to combination therapy
(zidovudine and lamivudine) [22,33], two exposure to HIV-
derived proteins [17,26] and one exposure to Simian Immun-
odeficiency Virus [30]. Thirteen used a CD-1 mouse model
[19–25,27,31–35], five a Sprague-Dawley rat model
[16,18,26,28,29], one a pigtailed macaque model [30] and one
an undisclosed rat model [17]. Sixteen studies looked at beha-
viour and development, while the remaining evaluated neuro-
logical biomarkers or structural differences in the brain.
Control groups included vehicle (often saline) (n = 12), both
vehicle and no treatment (n = 3), or no treatment (n = 2). All
studies were from the United States or Italy.
3.3 | Zidovudine
3.3.1 | Cognition/memory
Two studies reported that zidovudine-exposed mice (prepuber-
tal and young adult) showed either significant impairment or
trends towards impairment during the acquisition session of
the passive avoidance task, a memory test [19,20]. However,
retention of passive avoidance, spatial learning, and memory
were not impacted by zidovudine exposure [20,27], and when a
longer intra-session delay was introduced in a spatial learning
and memory task, zidovudine-exposed mice (100 mg/kg/day)
had improved performance over controls (p < 0.05) [27].
3.3.2 | Motor skills/nociception
In utero exposure to zidovudine alone [19,31], or with the
addition of a dopamine receptor D1 agonist [34], did not
affect locomotor activity of offspring. However, zidovudine-
exposed neonatal mice showed increased locomotor activity in
response to GABAergic agonist treatment early in life, but not
persisting into adulthood [31]. Zidovudine-exposed mice also
demonstrated increased nociceptive sensitivity at all ages that
was not dependent on GABA-regulated nociceptive mecha-
nisms [31].
3.3.3 | Anxiety/sociability
Studies measuring sociability and anxiety-related behaviours
report mixed findings. When given amphetamine to mimic a
stress response, two studies found that zidovudine-exposed
rats did not exhibit developmental delays that prohibited them
from reacting to the stress [16,18]. Zidovudine-exposed rats
had less wall-hugging behaviours (possibly indicative of lower
anxiety) and an increased locomotor response, but no differ-
ence in rearing or sniffing. The increased locomotor response
to amphetamine was only seen in females in one study [16],
but in both sexes in the other [18].
One study noted that prenatal exposure to zidovudine was
associated with reduced exploration of objects at all ages con-
sidered, increased wall- and top-rearing at specific ages, and
hyperactivity in adulthood [24]. However, another study
reported no significant differences in locomotion or rearing
between zidovudine-exposed mice and controls, even after
dopamine agonist injection [34].
Two studies had an additional focus on aggressive beha-
viours. In one, zidovudine exposure was associated with less
digging (p < 0.05), higher number of aggressive bouts in both
sexes (p < 0.05), and a tendency towards more inter-male
aggressive behaviours [19]. A second study looking at inter-
male aggressive behaviours reported alterations of both
aggressive and defensive actions, with zidovudine-exposed
mice having significantly more frequent aggressive behaviours
compared to controls in adolescent but not adult mice [32].
Several studies noted lower grooming frequencies in zidovu-
dine-exposed mice [18,24,34]. Lower grooming frequency was
also seen in zidovudine-exposed mice following administration
of dopamine receptor D1 agonist or amphetamine, which was
not the anticipated effect [18,34].
Exposure to zidovudine in utero was associated with a dose-
dependent increase in peak latency in the acoustic startle
response and enhanced tactile stimuli response [28,29]. Peri-
natal zidovudine exposure enhanced startle responses follow-
ing injection of amphetamine [28], apomorphine and serotonin
agonist [29]. These results may suggest abnormal nerve con-
duction velocity and long-term functional alterations within
the startle reflex pathways [28,29].
3.3.4 | Biomarkers
One study measured brain-derived neurotrophic factor
(BDNF) within various areas of the brain at multiple time
points [25]. In zidovudine-exposed mice, BDNF levels were
increased in the parietal cortex, hippocampus and hypothala-
mus compared to controls [25]. Sex differences in BDNF con-
centrations were observed in various brain regions, with
zidovudine-exposed females having increased BDNF levels in
the hippocampus, cortex and hypothalamus at various time
intervals and males having increased BDNF in the cortex at
one time interval [25].
3.3.5 | Learning/memory interventions
One study hypothesized that L-acetylcarnitine, an antioxidant
and neuroprotective factor, might improve ART-induced mito-
chondrial dysfunction and associated neuropathies [35]. The
study reported zidovudine-induced impairment of spatial learn-
ing and memory that was counteracted by L-acetylcarnitine
treatment (p < 0.05). In addition, zidovudine-exposed mice had
reduced expression of hippocampal metabotropic and ionotro-
pic glutamate receptors, which was counteracted by L-acetyl-
carnitine administration during pregnancy [35]. Of note, while
pups exposed to zidovudine in utero had undetectable levels of
the drug in plasma at birth, they had significant levels of zido-
vudine in their brain (70.2  6.1 ng/mg) [35].
3.4 | Lamivudine
3.4.1 | Cognition/memory
Studies investigating the impact of lamivudine exposure on
cognition and memory reported mixed results. In one study,
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lamivudine exposure in mice did not appear to affect acquisi-
tion and retention performance in passive avoidance tasks,
although there was a trend towards lamivudine-exposed mice
requiring more trials to reach acquisition (p = 0.066) [21]. A
study assessing long-term neurobehavioral effects reported
that lamivudine-exposed mice had a longer escape latency in
the reversal phase in the Morris water maze, suggesting
impaired reversal learning, but otherwise working and refer-
ence memory were not negatively impacted [23].
3.4.2 | Motor skills/nociception
One study reported that lamivudine-exposed mice (regard-
less of dose) had lower locomotor activity compared to con-
trols (p < 0.05) [21]. Male mice exposed to the highest
lamivudine dose tested showed decreased habituation in the
locomotor activity test (p < 0.05) [21]. Additionally, no
gross changes were seen in somatic and sensorimotor
development [21].
A study examining the impact of nucleoside analogues on
the GABAergic system reported increased locomotor activity
in lamivudine-exposed mice following administration of a
GABA receptor agonist at eight days of age, but this effect
was not seen later in life [31].
3.4.3 | Anxiety/sociability
One study looked at sociability in lamivudine-exposed mice.
Mice exposed in utero to lamivudine (500 mg/kg, the highest
dose tested) had non-specific alterations in sensitivity to a
muscarinic cholinergic antagonist (scopolamine), showing
increased sniffing behaviour (p = 0.0161) and decreased
immobility (p < 0.05) [23]. Lamivudine exposure in utero also
influenced maternal behaviour, with lamivudine-exposed moth-
ers showing higher rates of aggressive behaviour towards fos-
ter pups, manifesting in cannibalism [23].
3.5 | Combination therapy (zidovudine/lamivudine)
The first of two studies looking at a combination of zidovudine
and lamivudine examined the effect of in utero exposure on
cholinergic muscarinic neuroregulation in adulthood [22].
Responsiveness to a muscarinic cholinergic antagonist did not
differ significantly between ART-exposed mice and controls,
with similar habituation and response inhibition. However,
ART-exposed mice displayed a higher frequency of rearing
activities (p < 0.05) and a lower frequency and duration of
self-grooming behaviour (p < 0.05) [22], both behaviours that
involve the dopaminergic system [36,37].
The second study examined the effect of in utero exposure
to a combination of zidovudine and lamivudine on a variety of
neurobehavioral endpoints. ART exposure had a small but
marked delayed effect on somatic and sensorimotor develop-
ment, such as forelimb placing (p = 0.0025), forelimb stick
grasping (p = 0.05), level screen (p = 0.0093) and pole grasp-
ing (p = 0.0038) [33]. Additionally, ART-exposed mice had
selective alterations in social interaction tests, with females
displaying a significant reduction in affiliative interactions, such
as mutual circling (p = 0.0325) and allogrooming (p = 0.0055)
[33]. There was no effect on passive avoidance or locomotor
activity [33].
3.6 | HIV-derived proteins or SIV
One study looked at the impact of HIV-derived peptides on
the neurotoxicity of excitatory amino acid agonists. Rat pups
were administered the excitatory amino acid agonist N-
methyl-D-aspartate (NMDA) intracerebrally with or without
recombinant fusion peptide envelope gag (env-gag) on postna-
tal day 7, the equivalent of third trimester exposure for a
human foetus [17]. Histopathological scoring and measure-
ments of hippocampal cross-sectional areas showed that the
env-gag/NMDA injection rats had significantly more severe
brain injury (p < 0.003) compared to those with NMDA injec-
tions alone [17]. A similarly designed study looked at two
additional HIV-1 proteins, Tat and gp120 [26]. This study
found that Tat had an overall transient effect on many beha-
vioural assessments early in development and on pre-attentive
processes and spatial memory in adulthood, while gp120 had
more selective effects on negative geotaxis in neonates and
locomotor activity in adults [26]. This study also assessed the
relationship between behaviour and hippocampal anatomy, and
found 81% of the variance in spatial memory (searching beha-
viour in the probe test) was explained by the estimated num-
ber of neurons and astrocytes in the hilus of the dentate
gyrus [26].
One very small study using pigtailed macaques looked at
behaviour in offspring born to SIV-infected mothers [30]. Five
of the offspring were exposed but uninfected, and of these,
most completed various object permanence and cognitive test-
ing tasks slower than colony norms [30].
4 | DISCUSSION
This is the first systematic review of clinical and preclinical
studies focused on the cognitive implications of in utero HIV
or ART exposure. The few clinical studies in HEU children
have been mixed. Some found no difference in white matter
integrity relative to HUU children, while others reported
higher FA and lower diffusivity values, correlating with lower
neurobehavioral scores. The preclinical data provided a more
comprehensive view of differences in brain structure, beha-
viour, and biomarkers in models exposed to HIV proteins or
two antiretrovirals, with some adding information about how
the effects of exposure may persist into adulthood.
While the clinical data were limited, they did reveal some
intriguing findings for HEU children. In two of the three clini-
cal studies using DTI, regional increases in FA were noted in
HEU children, generally reflecting more densely packed axons,
greater axon diameter, or greater myelination. While increased
fractional anisotropy may represent higher white matter con-
nectivity [38,39], it has also been observed in pathological
conditions, such as autism [40] and attention-deficit disorder
[41]. Lower diffusivity values [12] correlating with lower neu-
robehavioral scores [12,15] were also seen in HEU children.
Lower diffusivity is thought to be related to denser white and
gray matter [39]. These findings may be due to other potential
confounders, such as poor maternal nutritional status and
other in utero stress, as these studies only adjusted for the
children’s sex and age. In another study [11], correlations
between DTI metrics and cognitive function fell in the more
typically expected direction, with better cognitive functioning
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correlating with higher FA and lower diffusivity. One of the
preclinical studies showed that neuronal and astrocyte density
in certain areas of the brain accounted for a majority of the
distribution in certain behavioural tasks [26]. Difference in
methodologies used to measure white matter and study par-
ticipant characteristics (e.g. age) make it difficult to speculate
on mechanisms underlying these potential differences
between HEU and HUU children and whether HIV and/or
ART play a role. More studies measuring white matter
changes and their relationship with clinical neurodevelopmen-
tal outcomes are needed to determine if differences exist
between HEU and HUU. Future research in this area would
provide the most benefit by having the following characteris-
tics: an adequately powered sample size in a longitudinal
cohort or a cross-sectional cohort with a large age band;
appropriate technical methodologies; and associated clinical
neurocognitive assessments. If a relationship between white
matter connectivity and axon density, cognitive delays, and
HIV and/or ART exposure was confirmed, it might allow us to
identify children at risk for neurodevelopmental impairments
at an earlier age, enabling timely intensive interventions pro-
viding maximal benefits.
Given increasing access, cognitive studies of HEU children
should consider including advanced neuroimaging. This will
help reconcile apparent discrepancies in the available studies
and clarify brain structure and function relationships within
this population. If relationships demonstrated in the prelimi-
nary work are replicated, these could be very informative in
terms of understanding potential later consequences for HEU
children. For example, the corona radiata is a white matter
structure connecting the brainstem and cerebral cortex, criti-
cal for sensorimotor function, while the uncinate fasciculus
and hippocampal cingulum are important for learning and
memory. Abnormalities in such white matter pathways may
therefore have important clinical implications for effective
development of such functions.
The preclinical data also revealed some important findings
regarding exposure to ART. For both zidovudine- and lamu-
vidine-exposed rodents, some studies suggested that memory
and learning may be impaired at early ages [19,23,27]. More
recent clinical studies with newer ART regimens have not found
such deficits in young children [2,3,42]. Fewer data are available
about specific cognitive functions in older HEU children and
adolescents, but studies have found a higher frequency of read-
ing and math impairments in HEU children compared to the
general population [43]. While this review does not clearly iden-
tify HIV or ART exposure as being associated with deficits in
cognition or memory, it does raise concerns regarding cognitive
development in HEU. The inconsistency of results between pre-
clinical data and clinical data in young children using neurode-
velopmental assessments should encourage researchers to
carefully consider methodologies used to assess neurodevelop-
ment in young children, specifically focusing on high-quality, cul-
turally and age-appropriate assessments and the use of
technologies such as MRI to best measure cognitive function.
Since some preclinical data reveal defects in younger mice that
do not persist into adulthood, longitudinal follow-up of HEU
children in future research is merited.
Social behaviours were another area of concern within the
pre-clinical data. Data suggest that ART-exposed mice displayed
less social behaviours, with significantly less affiliative
interactions [33], higher number of aggressive bouts [19,32], or
increased rates of maternal cannibalism of pups [23]. ART expo-
sure differed between studies, so the aetiology of the findings
remains unclear. However, little is known about social beha-
viours in HIV- and ART-exposed children and adults. Higher
rates of autism spectrum disorder have been found in HEU
populations; it is therefore hypothesized that mitochondrial dys-
function may be a contributing factor [44]. With the growing
population of HEU children worldwide, further research on their
long-term cognitive and social functioning is critically important.
Preclinical research has valuable potential to direct research
in humans. Animal models allow for mechanistic studies, which
yield clearer results compared to efforts in deciphering speci-
fic neurobiological pathways in humans. By including preclini-
cal studies, this review further explores potential effects
resulting from ART versus HIV exposure. Most preclinical
studies investigated the effects of ART monotherapy, specifi-
cally zidovudine and lamivudine, on cognitive function, illumi-
nating potential impact from the individual components of
many combination therapies. Other preclinical studies used
HIV proteins to mimic HIV-exposure in the absence of ART
exposure, deepening the understanding of the interplay
between HIV and ART exposure and brain development and
function, which is not possible in human studies. For example,
one study determined that zidovudine-exposed pups had high
concentrations of the drug in brain, but undetectable levels in
plasma [35]. Another study found elevated BDNF levels in the
parietal cortex of mice exposed to zidovudine in utero, with
females having particularly high levels [25]. These preclinical
studies generate important hypotheses to inform the design
of clinical studies, such as appropriate anatomical locations for
sampling or the possible influence of oestrogen on BDNF.
However, because of the limited number of studies within this
review, we were unable to disentangle the effects of ART
exposure from HIV exposure. Future preclinical research in
this area would benefit from choosing assessments that have
comparable measures in clinical research, which may be later
evaluated. This will strengthen our knowledge of potential
infant outcomes of ART or HIV exposure.
This review has some limitations. We did not expand our
search criteria to capture clinical studies looking at mitochon-
drial disorders and microcephaly in HEU children due to the
heterogeneity of this literature. This may hinder us from com-
prehensively describing other conditions impacting neurode-
velopment in HEU children. Also, our interpretation of the
clinical data within this review is limited by the heterogeneity
of the techniques used to determine structural or neurobio-
logical outcomes, as well as the age of the study participants.
While we were unable to hypothesize on a specific mechanism
for the structural differences present between HEU and HUU
children, we believe that the fact that structural differences
were found within the studies warrants further investigation
into brain structure and its relationship with clinical neurode-
velopmental outcomes as children mature. Additionally, this
review was limited by the lack of power calculations, small
sample sizes, and the absence of point estimate and 95% con-
fidence interval reporting. These statistical issues limited confi-
dence in the reported results and understanding of how the
small sample size may have impacted the results. The potential
effects of modern ART regimens were not considered, as most
preclinical studies were > 15 years old.




Due to the complexities of cognitive assessments and con-
founding variables impacting neurodevelopment, the current
literature on neurodevelopment in HEU and HUU children
does not clearly indicate whether there are differences
between these children. This review summarizes objective
data from both clinical and preclinical studies. The combined
literature suggests possible differences in white matter con-
nectivity in clinical studies and memory and sociability differ-
ences in preclinical studies, although the applicability of these
data is limited. However, due to the abnormalities in brain
structure, function and biochemistry found in HEU compared
to HUU, this is an area where more systematic and transla-
tional work is needed. Future preclinical studies should con-
sider looking at specific mechanisms of neurobiological
changes and use ART exposures and neurobehavioral assess-
ments that harmonize with current clinical standards. More
clinical research is needed comparing the neurobiological fac-
tors between HEU and HUU, with a focus on domains found
to be impacted in preclinical research, such as memory and
sociability. In doing this, we will take steps in determining the
clinical implications of in utero HIV and ART exposure.
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